AAPS announces 1999 award winners

October 19, 1999

ALEXANDRIA, Va.--The American Association of Pharmaceutical Scientists (AAPS) is pleased to announce the winners of its annual awards for excellence in the pharmaceutical sciences. The awards will be presented by AAPS President Larry Augsburger, Ph.D. at the 1999 AAPS Annual Meeting on Nov. 14, 1999, in New Orleans.

Robinson Receives AAPS Distinguished Pharmaceutical Scientist Award

Joseph R. Robinson, Ph.D. will receive the 1999 AAPS Distinguished Pharmaceutical Scientist Award. Dr. Robinson is a pioneer in the area of controlled drug delivery with particular focus in the use of bioadhesive polymers and ocular drug disposition and delivery. He is professor of Pharmacy & Ophthalmology at the University of Wisconsin-Madison, and a past president of both AAPS and the Controlled Release Society. Sponsored by Zeneca Pharmaceuticals, the AAPS Distinguished Pharmaceutical Scientist Award recognizes distinguished work in advancing the pharmaceutical sciences and AAPS.

AAPS Research Achievement Awards

The AAPS Research Achievement Awards recognize outstanding scientists who have conducted research that has had a significant impact in the pharmaceutical science field.

Charles Russell Middaugh, Ph.D. will receive the 1999 AAPS Research Achievement Award in Biotechnology. Dr. Middaugh is especially well known for his work in the area of protein and polynucleotide formulation and characterization. He is the Aya and Takeru Higuchi Distinguished Professor of Pharmaceutical Chemistry at the University of Kansas. This award is sponsored by Hoffmann-LaRoche, Inc.

Milap C. Nahata, M.S., Pharm.D. will receive the 1999 AAPS Research Achievement Award in Clinical Sciences. Dr. Nahata has published more than 350 peer-reviewed articles on clinical pharmacokinetics, pharmacodynamics and the efficacy, adverse effects, interaction, stability and compatibility of drugs used in pediatric patients. He is the Charles H. Kimberly Professor of Pharmacy and Chair of the Pharmacy Practice and Administration, College of Pharmacy, Ohio State University. This award is sponsored by Axelson BioPharma Research, Inc.

Tsuneji Nagai, Ph.D. will receive the 1999 AAPS Research Achievement Award in Pharmaceutics and Drug Delivery. Dr. Nagai is well known for his research in the area of bioavailability studies and controlled drug delivery formulations. Dr. Nagai is Professor Emeritus in the Department of Pharmaceutics at Hoshi University, Tokyo, Japan. This award is sponsored by Searle.

Nicholas A. Peppas, Sc.D. will receive the 1999 AAPS Research Achievement Award in Pharmaceutical Technologies. Dr. Peppas is internationally known for his research on hydrogels used in the controlled delivery of drugs and proteins, his development of new mucoadhesive delivery systems and his study of novel biomaterials. He is the Showalter Distinguished Professor of Chemical and Biomedical Engineering at Purdue University. This award is sponsored by SmithKline Beecham Pharmaceuticals.

AAPS New Investigator Grant in Pharmaceutics and the Pharmaceutical Technologies

Jeffrey A. Hughes, Pharm.D., Ph.D. will receive the 1999 AAPS New Investigator Grant in Pharmaceutics and Pharmaceutical Technologies. Dr. Hughes' research has focused on the intracellular fate of macromolecules to enhance therapeutic approaches for the treatment of Alzheimer's Disease, tuberculosis and hypertension. He is associate professor in the Department of Pharmaceutics at the University of Florida. This grant is sponsored by Pfizer Central Research.

AAPS New Investigator Grant in Oral Lipids-Based Drug Delivery Systems

Christopher J.H. Porter, Ph.D. will receive the 1999 AAPS New Investigator Grant in Oral Lipids-Based Drug Delivery Systems. Dr. Porter's most significant contributions to the pharmaceutical sciences include improving the understanding of the impact of lipids on the absorption, distribution, lymphatic transport and bioavailability of water-soluble drugs after oral administration. He is lecturer in Pharmaceutics at Monash University's Victorian College of Pharmacy, Victoria, Australia. This grant is sponsored by GattefossÄ, s.a.

Outstanding Manuscript Award

Shewan M. Aziz, R.Ph., Ph.D.; Mustafa Yatin, Ph.D.; David R. Worthen, R.Ph., M.S., D.R.W.; David W. Lipke, Ph.D.; and Peter A. Crooks, Ph.D. will receive the 1999 AAPS Outstanding Manuscript Award in Analysis and Pharmaceutical Quality for their paper entitled "Novel Techniques for Visualizing the Intracellular Localization and Distribution of Transported Polyamines in Cultured Pulmonary Artery Smooth Muscle Cells." The paper was published in the Journal of Pharmaceutical and Biomedical Analysis, 17, 307-320 (1998).

Meritorious Manuscript Award

Zheng Yang, Ph.D.; Richard C. Brundage, Pharm.D., Ph.D.; Rashmi H. Barbhaiya, Ph.D.; and Ronald J. Sawchuk, Ph.D. will receive the 1999 AAPS Meritorious Manuscript Award for their paper entitled "Microdialysis Studies of the Distribution of Stavudine into the Central Nervous System in Freely-Moving Rats." This paper was published in Pharmaceutical Research, 14, 865-872 (1997). This award is sponsored by Pfizer Central Research.
AAPS is a professional, scientific society of more than 9,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS aims to advance science through the open exchange of scientific knowledge, serve as an information resource, and contribute to human health through pharmaceutical research and development. For more information about AAPS, visit AAPS Online at http://www.aaps.org.

American Association of Pharmaceutical Scientists

Related Drug Delivery Articles from Brightsurf:

Modelling microswimmers for drug delivery
An international group of theoretical physicists led by Abdallah Daddi-Moussa-Ider from Düsseldorf, Germany, has modelled the motion of microscopic, motile bodies - either powered micro-machines or living cells - in viscous liquid drops, using the Navier-Stokes equations.

Millimetre-precision drug delivery to the brain
Focused ultrasound waves help ETH researchers to deliver drugs to the brain with pinpoint accuracy, in other words only to where their effect is desired.

New smart drug delivery system may help treatment for neurological disorders
A Rutgers-led team has created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other neurological disorders.

Novel drug delivery particles use neurotransmitters as a 'passport' into the brain
Drug-carrying lipid nanoparticles were created that incorporate neurotranmitters to help them cross the blood-brain barrier in mice.

Advances in nanoparticles as anticancer drug delivery vector: Need of this century
This review article provides a summary of current advances in the use of nanoparticles (NPs) as anticancer drug-delivery vectors.

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.

Improving drug delivery for brain tumor treatment
Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.

Nanoparticle orientation offers a way to enhance drug delivery
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling an inherent trait of chemical structures, known as chirality -- the 'handedness' of the structure.

News about drug delivery
Nanocontainer for drugs can have their pitfalls: If they are too heavily loaded, they will only dissolve poorly.

Deflating beach balls and drug delivery
Gwennou Coupier and his colleagues at Grenoble Alps University, Grenoble, France have shown that macroscopic-level models of the properties of microscopic hollow spheres agree very well with theoretical predictions.

Read More: Drug Delivery News and Drug Delivery Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.